Biologic hernia repair mesh market to hit $2.46B by 2029 at 7.4% CAGR, driven by advanced implants, minimally invasive surgeries, and tissue engineering.
Read MoreBio-detectors and accessories market to reach $42.88B by 2029 at 15.9% CAGR, driven by biosurveillance, real-time detection, and AI-powered systems.
Read MoreBiodegradable hemostat market to hit $1.48B by 2029 at 10.9% CAGR, driven by surgical demand, biodegradable tech, and innovations in wound care.
Read MoreBioabsorbable surgical mesh market to reach $1.73B by 2029 at 8.6% CAGR, driven by absorbable materials, minimally invasive tech, and product innovation.
Read MoreAtrial fibrillation devices market to hit $13.28B by 2029 at 11.5% CAGR, driven by advanced treatments, AI integration, and minimally invasive systems.
Read MoreAsthma treatment market to reach $28.27B by 2029 at 4.5% CAGR, driven by biologics, personalized care, digital inhalers, and AI-powered management.
Read MoreAsthma Therapeutics Market – Opportunities, Share, Growth and Competitive Analysis and Forecast 2029
Asthma therapeutics market to hit $44.53B by 2029 at 7.7% CAGR, driven by biologics, personalized care, smart inhalers, and AI-based asthma monitoring.
Read MoreAsthma disease market to reach $31.56B by 2029 at 5% CAGR, driven by biologics, personalized care, smart inhalers, and AI-powered asthma management.
Read MoreAssistive technology for low vision market to hit $1.57B by 2029 at 8.5% CAGR, driven by wearable devices, AI aids, and smartphone-integrated solutions.
Read MoreAseptic connectors and welders market to reach $3.96B by 2029 at 18.1% CAGR, driven by biologics growth, single-use tech, and automated aseptic systems.
Read More